Bio-Rad Laboratories Price to Book Ratio 2010-2023 | BIO
Historical price to book ratio values for Bio-Rad Laboratories (BIO) over the last 10 years. The current price to book ratio for Bio-Rad Laboratories as of April 26, 2024 is 0.90.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Bio-Rad Laboratories Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-04-26 | 275.94 | 0.90 | |
2023-12-31 | 322.89 | $306.50 | 1.05 |
2023-09-30 | 358.45 | $288.77 | 1.24 |
2023-06-30 | 379.12 | $290.51 | 1.31 |
2023-03-31 | 479.02 | $329.77 | 1.45 |
2022-12-31 | 420.49 | $324.88 | 1.29 |
2022-09-30 | 417.14 | $283.45 | 1.47 |
2022-06-30 | 495.00 | $300.44 | 1.65 |
2022-03-31 | 563.23 | $340.09 | 1.66 |
2021-12-31 | 755.57 | $457.21 | 1.65 |
2021-09-30 | 745.95 | $512.48 | 1.46 |
2021-06-30 | 644.29 | $389.46 | 1.65 |
2021-03-31 | 571.17 | $356.45 | 1.60 |
2020-12-31 | 582.94 | $331.05 | 1.76 |
2020-09-30 | 515.46 | $295.84 | 1.74 |
2020-06-30 | 451.49 | $247.77 | 1.82 |
2020-03-31 | 350.56 | $212.27 | 1.65 |
2019-12-31 | 370.03 | $192.31 | 1.92 |
2019-09-30 | 332.74 | $171.41 | 1.94 |
2019-06-30 | 312.59 | $184.12 | 1.70 |
2019-03-31 | 305.68 | $163.11 | 1.87 |
2018-12-31 | 232.22 | $134.91 | 1.72 |
2018-09-30 | 312.99 | $163.55 | 1.91 |
2018-06-30 | 288.54 | $155.49 | 1.86 |
2018-03-31 | 250.08 | $150.58 | 1.66 |
2017-12-31 | 238.67 | $98.38 | 2.43 |
2017-09-30 | 222.22 | $95.70 | 2.32 |
2017-06-30 | 226.31 | $94.90 | 2.38 |
2017-03-31 | 199.34 | $91.45 | 2.18 |
2016-12-31 | 182.28 | $87.20 | 2.09 |
2016-09-30 | 163.81 | $91.49 | 1.79 |
2016-06-30 | 143.02 | $88.86 | 1.61 |
2016-03-31 | 136.72 | $86.55 | 1.58 |
2015-12-31 | 138.66 | $84.83 | 1.63 |
2015-09-30 | 134.31 | $82.91 | 1.62 |
2015-06-30 | 150.61 | $80.89 | 1.86 |
2015-03-31 | 135.18 | $75.46 | 1.79 |
2014-12-31 | 120.56 | $75.17 | 1.60 |
2014-09-30 | 113.40 | $75.16 | 1.51 |
2014-06-30 | 119.71 | $77.94 | 1.54 |
2014-03-31 | 128.12 | $77.47 | 1.65 |
2013-12-31 | 123.61 | $75.99 | 1.63 |
2013-09-30 | 117.56 | $74.10 | 1.59 |
2013-06-30 | 112.20 | $72.44 | 1.55 |
2012-12-31 | 105.05 | $70.77 | 1.48 |
2012-09-30 | 106.72 | $68.23 | 1.56 |
2012-06-30 | 100.01 | $65.46 | 1.53 |
2012-03-31 | 103.69 | $65.15 | 1.59 |
2011-12-31 | 96.04 | $61.89 | 1.55 |
2013-03-31 | 126.00 | $71.21 | 1.77 |
2011-09-30 | 90.77 | $60.23 | 1.51 |
2011-06-30 | 119.36 | $61.51 | 1.94 |
2011-03-31 | 120.14 | $57.63 | 2.08 |
2010-12-31 | 103.85 | $55.31 | 1.88 |
2010-09-30 | 90.51 | $51.38 | 1.76 |
2010-06-30 | 86.49 | $47.08 | 1.84 |
2010-03-31 | 103.52 | $47.14 | 2.20 |
2009-12-31 | 96.46 | $46.47 | 2.08 |
2009-09-30 | 91.88 | $44.68 | 2.06 |
2009-06-30 | 75.48 | $41.14 | 1.83 |
2009-03-31 | 65.90 | $38.68 | 1.70 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $7.869B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
Stryker (SYK) | United States | $127.690B | 31.66 |
Boston Scientific (BSX) | United States | $107.347B | 34.19 |
Medtronic (MDT) | Ireland | $105.881B | 14.99 |
EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
ResMed (RMD) | United States | $32.074B | 30.08 |
Terumo (TRUMY) | Japan | $24.746B | 34.95 |
Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
Baxter (BAX) | United States | $20.379B | 14.86 |
Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
Insulet (PODD) | United States | $11.637B | 61.10 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
Haemonetics (HAE) | United States | $4.621B | 23.63 |
Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
Envista Holdings (NVST) | United States | $3.504B | 13.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
ICU Medical (ICUI) | United States | $2.311B | 17.24 |
TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
Owens & Minor (OMI) | United States | $1.922B | 18.45 |
Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
InMode (INMD) | Israel | $1.439B | 7.45 |
National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
Warby Parker (WRBY) | United States | $1.271B | 0.00 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.911B | 0.00 |
Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
Evolus (EOLS) | United States | $0.662B | 0.00 |
Jin Medical (ZJYL) | China | $0.626B | 0.00 |
Quanterix (QTRX) | United States | $0.595B | 0.00 |
Valneva SE (VALN) | France | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
PetIQ (PETQ) | United States | $0.486B | 18.16 |
TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
ZimVie (ZIMV) | United States | $0.431B | 26.37 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
Zynex (ZYXI) | United States | $0.361B | 41.52 |
Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
Cerus (CERS) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
InterCure (INCR) | Israel | $0.121B | 20.46 |
Fonar (FONR) | United States | $0.103B | 8.84 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.77 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |